HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
Inflammatory Bowel Disease Center News & Announcements
1 - 11 of 11
Published on May 30, 2025 in Cornerstone Blog
Research news highlights a science breakthrough in CRISPR gene editing, and stem cell transplants provide curative potential for monogenic inflammatory bowel disease.
Published on May 20, 2025 in Press Releases
Researchers found that hematopoietic stem cell transplantation is effective for treating patients with monogenic inflammatory bowel disease.
Published on May 13, 2025 in Cornerstone Blog
Scientists, staff, and students from CHOP and the University of Pennsylvania community celebrated the next generation of pediatric researchers and the continuation of collaborative scientific discovery at the Poster Day and Scientific Symposium.
Published on Sep 4, 2024 in Announcements
The Center for Microbial Medicine was designated a Center of Emphasis beginning July 1, 2024.
Published on May 15, 2023 in Cornerstone Blog
This year’s Poster Day and Scientific Symposium featured all manners of bugs, breakthroughs, and big discoveries.
Published on Sep 21, 2022 in Cornerstone Blog
A high school student in the lab of Dr. Kathryn Hamilton won two science fair awards for research he conducted at CHOP.
Published on Apr 29, 2022 in Cornerstone Blog
Read about the latest discoveries and awards at Children’s Hospital of Philadelphia Research Institute.
Published on Mar 10, 2020 in Press Releases
Nutritional therapies can lead to improved medical outcomes, as well as support growth and development for children with IBD.
Published on May 18, 2018 in Cornerstone Blog
This week in the news, research from the Cardiac Center and the Division of Urology make headlines for children's health.
Published on Sep 10, 2015 in Cornerstone Blog
Melding together genomics technology, disease patterns, immunology, and microbiology, physician-scientists at The Children’s Hospital of Philadelphia are finding new and individualized therapies for patients with very early onset inflammatory bowel disease.
Published on Jun 18, 2015 in Cornerstone Blog
A study published in the Journal of Clinical Endicronology & Metabolism shows a drug approved to treat Crohn’s disease and ulcerative colitis leads to “rapid improvements” in bone density and structure.